1 completed, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
Follow Adverse Event: new trials by email Literature Review of Adverse Event trials Research Report on Adverse Event
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intramuscular Ketorolac at Two Single-Dose Regimens Ketorolac Injection 15 mg, Ketorolac Injection 60 mg - Musculoskeletal Pain, Analgesia | Phase 4 | Completed | William Beaumont Army Medical Center | 110 | 2020-06-27 | 2025-10-15 |
| Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes Allisartan Isoproxil, Amlodipine 5mg, Standard treatment by current guideline - Diabetes Mellitus, Type 2, Adverse Event | Phase 4 | Recruiting | XueQing Yu | 11414 | 2018-02-01 | 2026-09-14 |
Agnosia (1) · Diabetes Mellitus, Type 2 (1) · Emergencies (1) · Musculoskeletal Pain (1) · Prehypertension (1)
Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Nutritional and Metabolic Diseases (1) · Pain (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Amlodipine (1) · Ketorolac (1) · Ketorolac Tromethamine (1) · allisartan isoproxil (1)
William Beaumont Army Medical Center (1) · XueQing Yu (1)
China (1) · United States (1)
Jiyan Chen, MD (1) · Nathaniel J Turner, MPAS (1)